findmyKOL
Clinical trialNCT02115048TerminatedPhase 2Interventional

Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

SponsorTranslational Research in OncologyEnrollment44Breast Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bosnia and Herzegovina
  • University Hospital Clinical Center Banja Luka, Oncology Clinic

    Banja Luka, Bosnia and Herzegovina

  • Clinical Center of University in Sarajevo, Clinic for Oncology

    Sarajevo, Bosnia and Herzegovina

  • University Clinical Center Tuzla Clinic for Oncology, Hematology and Radiotherapy

    Tuzla, Bosnia and Herzegovina

Romania
  • Filantropia Clinical Hospital

    Bucharest, Romania

  • County Emergency Clinical Hospital Cluj-Napoca Oncology Department

    Cluj-Napoca, Romania

  • Sc Medisprof Srl

    Cluj-Napoca, Romania

  • County Hospital Ploiesti

    Ploieşti, Romania

  • County Emergency Hospital "sf Ioan Cel Nou"

    Suceava, Romania

  • Oncomed Srl Timisoara

    Timișoara, Romania

Spain
  • Complexo Hospitalario Universitario A Coruña

    A Coruña, Spain

  • Complejo Hospitalario Universitario de Albacete

    Albacete, Spain

  • Hospital General Universitario de Alicante

    Alicante, Spain

  • Hospital de Especialidades de Jerez de la Frontera

    Jerez de la Frontera, Spain

  • Hospital Clínico Universitario Virgen de la Arrixaca

    Murcia, Spain

  • Hospital Son Llatzer

    Palma de Mallorca, Spain

  • Hospital Universitari de Sant Joan de Reus

    Reus, Spain

  • Hospital Universitario Miguel Servet

    Zaragoza, Spain

United States
  • St. Jude Heritage Healthcare

    Fullerton, California, United States

  • University of California Los Angeles Hematology Oncology

    Los Angeles, California, United States

  • West Valley Hematology Oncology Medical Group

    Northridge, California, United States

  • Dba Torrance Memorial Physician Network/cancer Care Associates

    Redondo Beach, California, United States

  • Coastal Integrative Cancer Care

    San Luis Obispo, California, United States

  • Central Coast Medical Oncology Corporation

    Santa Maria, California, United States

  • Orlando Health, Inc.

    Orlando, Florida, United States

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, United States

  • Hope Women'S Cancer Centers

    Asheville, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2014
Primary completion
30 Nov 2018
Completion
30 Nov 2018
Last update posted
26 Dec 2019
Registered enrollment
44
Registry id
NCT02115048

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.